| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130130906 Substituted 6-(alkylbenzylamino) purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives |
| 05/23/2013 | US20130129651 Agent for enhancing the effect of skin-whitening ingredients and uses thereof |
| 05/23/2013 | CA2855950A1 Kinase modulating compounds, compositions containing the same and use thereof |
| 05/22/2013 | EP2594569A1 Entecavir synthesis method and intermediate compound thereof |
| 05/22/2013 | EP2593455A1 Purine compounds selective for i3 p110 delta, and methods of use |
| 05/22/2013 | CN103113371A Acyclovir eutectic and preparation method thereof and preparation |
| 05/21/2013 | US8445487 Purine PI3K inhibitor compounds and methods of use |
| 05/16/2013 | WO2013070887A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections |
| 05/16/2013 | WO2013068438A1 Purine derivatives for the treatment of viral infections |
| 05/16/2013 | WO2013067597A1 Immunomodulatory conjugates |
| 05/16/2013 | US20130123283 Methods and compostions for treating pain |
| 05/16/2013 | US20130123282 Solid state forms of linagliptin |
| 05/16/2013 | US20130123281 Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules |
| 05/16/2013 | US20130123280 A2b adenosine receptor antagonists |
| 05/16/2013 | CA2850448A1 Purine derivatives for the treatment of viral infections |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof |
| 05/14/2013 | US8440678 Pharmaceutical composition |
| 05/14/2013 | US8440677 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 05/14/2013 | US8440661 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines |
| 05/10/2013 | WO2013064984A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/10/2013 | WO2012112548A3 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis |
| 05/10/2013 | CA2855019A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/09/2013 | US20130116266 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 05/09/2013 | US20130116262 Bicyclic piperazine compounds |
| 05/08/2013 | EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 05/08/2013 | CN103097354A Substituted benzamide compounds |
| 05/08/2013 | CN103087133A Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/07/2013 | US8436029 Pharmaceutical forms, and methods of making and using the same |
| 05/02/2013 | WO2013063417A1 Methyltransferase inhibitors for treating cancer |
| 05/02/2013 | WO2013062945A1 Chemical compounds |
| 05/02/2013 | WO2013061305A1 Novel purine derivatives and their use in the treatment of disease |
| 05/02/2013 | WO2012031138A9 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione |
| 05/02/2013 | US20130109704 Purinyl derivatives and their use as potassium channel modulators |
| 05/02/2013 | CA2853633A1 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies |
| 05/02/2013 | CA2853501A1 Methyltransferase inhibitors for treating cancer |
| 05/02/2013 | CA2853256A1 Novel purine derivatives and their use in the treatment of disease |
| 05/01/2013 | EP2585464A2 Substituted 2-(9h-purin-9-yl) acetic acid analogues as inhibitors of stat3 |
| 05/01/2013 | EP2585462A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 05/01/2013 | CN101820881B Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treament of inflammation |
| 04/30/2013 | US8431583 Use of purine derivatives for the manufacture of a medicament |
| 04/25/2013 | WO2013058681A2 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof |
| 04/25/2013 | WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | WO2012166706A3 Supramolecular nanofibers and hydrogels based on oligopeptides functionalized with nucleobases |
| 04/25/2013 | US20130102576 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/24/2013 | CN103059024A Functionalized ion liquid and application thereof |
| 04/24/2013 | CN103059023A Method for preparing ganciclovir crystal form II |
| 04/24/2013 | CN103059022A Purine derivative and pharmaceutical application thereof |
| 04/24/2013 | CN102321086B Synthesizing method of adenine |
| 04/24/2013 | CN101503408B 8-(3-amino-piperidin-1-yl)-xanthines |
| 04/23/2013 | US8426377 iRNA agents with biocleavable tethers |
| 04/23/2013 | CA2610042C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/18/2013 | US20130096134 Heterocyclic compounds and their uses |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | US20130096104 Imidazopyridine compounds, compositions and methods of use |
| 04/17/2013 | CN103044427A Refining and purification method of medical-grade adenine |
| 04/17/2013 | CN103044426A Ganciclovir crystal compound, new composition thereof and preparation method thereof |
| 04/17/2013 | CN103044425A Active carbon and caffeine separation pyrolysis apparatus |
| 04/17/2013 | CN102250093B Process for recovering theophylline sodium salt from theophylline sodium salt mother liquid |
| 04/17/2013 | CN101903389B Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 04/16/2013 | US8420813 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 04/16/2013 | US8420354 Methods to manufacture 1,3-dioxolane nucleosides |
| 04/16/2013 | US8420049 Labeled adenosine for use in positron emission tomography |
| 04/10/2013 | EP2578585A1 Purinone derivative |
| 04/10/2013 | EP2578584A1 Arylamino purine derivatives, preparation method and pharmaceutical use thereof |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |
| 04/10/2013 | EP2576565A1 Carbanucleoside synthesis and novel intermediate compounds useful therein |
| 04/10/2013 | EP2576556A1 Process for the synthesis of carbonucleoside and intermediates for use therein |
| 04/10/2013 | EP2576541A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 04/10/2013 | CN103038230A Aminopyrimidine derivatives as LRRK2 modulators |
| 04/10/2013 | CN102050843B Method for extracting alkaloid and catechin from tea |
| 04/10/2013 | CN101781301B Method for preparing entecavir |
| 04/04/2013 | US20130085276 Carboxylation catalysts |
| 04/04/2013 | US20130085150 Analogues for the treatment or prevention of flavivirus infections |
| 04/04/2013 | US20130085139 Oligomers |
| 04/03/2013 | CN103012405A New adenine type compound |
| 04/03/2013 | CN103012404A Polymorphic substance of valganciclovir hydrochloride and medical composition thereof |
| 04/03/2013 | CN103012403A Tea leaf comprehensive utilizing and deep processing method |
| 04/03/2013 | CN103012402A Method for extracting caffeine from tea |
| 04/02/2013 | US8410119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/02/2013 | US8409593 Methods for reducing tackiness associated with a xanthine compound |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 03/28/2013 | US20130079512 Pyrimidine substituted purine derivatives |
| 03/28/2013 | US20130079327 Purinone derivative |
| 03/28/2013 | US20130079324 Pyrrolopyrimidine and purine derivatives |
| 03/28/2013 | US20130079303 Inhibitors of PI3 Kinase and/or mTOR |
| 03/28/2013 | CA2845409A1 Imidazopyridine compounds, compositions and methods of use |
| 03/27/2013 | CN103003279A Purine compounds selective for Pi3K P110 delta, and methods of use |
| 03/27/2013 | CN102993265A Immune receptor regulator couplet as well as preparation method and application thereof, coupling precursor for preparing immune receptor regulator couplet and compound for compounding coupling precursor |
| 03/27/2013 | CN102993203A Preparation of 8-benzyl xanthine derivative and application |
| 03/27/2013 | CN102336755B Chemical synthesis method of 6-chloropurine |
| 03/27/2013 | CN102234281B Pyrimidine-fused cyclic derivative |
| 03/27/2013 | CN101679287B Nicotinic acetylcholine receptor modulators |
| 03/26/2013 | US8404838 Inhibitors of tyrosine kinase receptor dimerization |
| 03/26/2013 | CA2631737C Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes |